TORONTO, ON / ACCESSWIRE / December 14, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company") (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing ...
Sales revenues in Q3 2015 were 186% higher at $383,791 as compared to $134,036 in Q3 2014. Revenues in Canada increased by 43% while U.S. revenues decreased by 42% and international revenues decreased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback